Simplify Propel Opportunities ETF Rating → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free SURI Stock Alerts $22.10 -0.49 (-2.17%) (As of 05/10/2024 06:40 PM ET) Add Compare Share Share RatingsStock AnalysisChartDividendHoldingsRatingsStock AnalysisChartDividendHoldingsRatings Simplify Propel Opportunities ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SURI Aggregate RatingModerate Buy2.78Holdings in SURI have an aggregate rating of Moderate Buy based on 125 analyst ratings issued in the past year covering 21 companies (90.2% of the portfolio).SURI Aggregate Price Target$40.4182.85% UpsideHigh Prediction$50.55Average Prediction$40.41Low Prediction$26.17Holdings in SURI have an aggregate price target of $40.41 and a range of $26.17 to $50.55 covering 21 companies (90.2% of the portfolio).SURI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Propel Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 SURI Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings27.74%PAGPPlains GP$18.28-1.0%3 of 5 stars2.60$19.64 7.4%1013.00%APLTApplied Therapeutics$4.46+1.6%5 of 5 stars3.00$11.00 146.6%5Short Interest ↓8.26%TCRXTScan Therapeutics$7.78+0.6%3 of 5 stars3.00$12.50 60.7%4Upcoming EarningsAnalyst Forecast5.16%PHATPhathom Pharmaceuticals$9.80+2.9%2 of 5 stars2.75$22.00 124.5%4Earnings ReportAnalyst Forecast4.89%AKROAkero Therapeutics$20.81+5.9%3 of 5 stars2.86$37.71 81.2%7Analyst ForecastShort Interest ↑4.85%MDGLMadrigal Pharmaceuticals$216.47+5.5%5 of 5 stars2.73$345.09 59.4%11Earnings ReportAnalyst ForecastAnalyst Revision3.58%FULCFulcrum Therapeutics$7.73+3.5%2 of 5 stars2.83$13.17 70.3%6Short Interest ↑News CoverageGap Up3.43%CASHPathward Financial$54.09+0.2%3 of 5 stars2.50$63.00 16.5%2Dividend Announcement3.28%RNAAvidity Biosciences$26.53+2.2%1 of 5 stars3.00$38.29 44.3%7Analyst Forecast3.09%ATHAAthira Pharma$2.20+3.8%2 of 5 stars3.00$12.00 445.5%12.42%ARDXArdelyx$7.93+2.1%4 of 5 stars3.11$12.81 61.6%9Gap Down2.32%TSATTelesat$7.45+3.3%2 of 5 stars2.00$9.00 20.8%11.85%MIRMMirum Pharmaceuticals$25.41+2.6%5 of 5 stars3.10$49.73 95.7%10Analyst ForecastAnalyst RevisionGap Down1.69%KURAKura Oncology$20.51-1.0%3 of 5 stars2.88$28.28 37.9%81.13%SNDXSyndax Pharmaceuticals$21.47-1.3%3 of 5 stars2.91$34.42 60.3%11Earnings ReportAnalyst RevisionNews Coverage1.10%KYMRKymera Therapeutics$38.66+2.0%0 of 5 stars2.50$41.10 6.3%121.08%ACHVAchieve Life Sciences$4.73+2.6%1 of 5 stars3.00$16.33 245.3%3Gap Up0.60%TRVITrevi Therapeutics$2.61-4.4%2 of 5 stars3.00$8.50 225.7%2Analyst RevisionNews Coverage0.50%XFORX4 Pharmaceuticals$1.04-1.4%4 of 5 stars2.50$3.67 254.3%2Analyst RevisionGap Up0.19%CYBNCybin$0.36-1.0%2 of 5 stars3.00$7.50 1,989.1%30.04%STROSutro Biopharma$4.23+1.9%5 of 5 stars3.00$12.50 195.5%8Upcoming EarningsNews Coverage This page (NYSEARCA:SURI) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThis 1 Biotech Stock has been shocking the marketsHuge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe Crypto 9-5 Escape PlanCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Propel Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
